Effect of phenylmethylsulfonyl fluoride on the potency of anandamide as an inhibitor of electrically-evoked contractions in 2 isolated tissue preparations

Roger Guy Pertwee, S R Fernando, G Griffin, V Abadji, A Makriyannis

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The endogenous cannabinoid receptor ligand, anandamide, produced a concentration related inhibition of electrically evoked contractions of the guinea-pig myenteric plexus preparation. Its potency was markedly enhanced by phenylmethylsulphonyl fluoride (2.0-200 mu M) which presumably acts by inhibiting the hydrolysis of anandamide in this preparation. The degree of this potentiation increased with the concentration of phenylmethylsulphonyl fluoride used. The methyl analogue of anandamide, R-(+)-arachidonyl-l'-hydroxy-2'-propylamide, also inhibited contractions of the guinea-pig myenteric plexus preparation. The potency of this compound was much less affected by phenylmethylsulphonyl fluoride than was the potency of anandamide, confirming its greater resistance to hydrolysis. Phenylmethylsulphonyl fluoride did not alter the inhibitory potency of the cannabinoid, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxypropyl]cyclohexan-1-ol), which is not an amidase substrate. Nor did phenylmethylsulphonyl fluoride affect the ability of anandamide to inhibit electrically evoked contractions of the mouse vas deferens, suggesting that anandamide does not undergo hydrolysis in this tissue.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalEuropean Journal of Pharmacology
Volume272
Issue number1
DOIs
Publication statusPublished - 5 Jan 1995

Keywords

  • CANNABINOID
  • PHENYLMETHYLSULFONYL FLUORIDE
  • ANANDAMIDE
  • R-(+)-ARACHIDONYL-1'-HYDROXY-2'-PROPYLAMIDE VAS DEFERENS, MOUSE
  • MYENTERIC PLEXUS PREPARATION, GUINEA-PIG
  • CANNABINOID RECEPTOR
  • MYENTERIC PLEXUS
  • GUINEA-PIG
  • cannabinoid
  • phenylmethylsulfonyl fluoride
  • anandamide
  • R-(+)-arachidonyl-1-hydroxy-2'-propylamide vas deferens
  • mouse
  • myenteric plexus preparation
  • guinea-pig

Cite this

Effect of phenylmethylsulfonyl fluoride on the potency of anandamide as an inhibitor of electrically-evoked contractions in 2 isolated tissue preparations . / Pertwee, Roger Guy; Fernando, S R ; Griffin, G ; Abadji, V ; Makriyannis, A .

In: European Journal of Pharmacology, Vol. 272, No. 1, 05.01.1995, p. 73-78.

Research output: Contribution to journalArticle

@article{b50ef9d98cd14f26a317fca69c3aea73,
title = "Effect of phenylmethylsulfonyl fluoride on the potency of anandamide as an inhibitor of electrically-evoked contractions in 2 isolated tissue preparations",
abstract = "The endogenous cannabinoid receptor ligand, anandamide, produced a concentration related inhibition of electrically evoked contractions of the guinea-pig myenteric plexus preparation. Its potency was markedly enhanced by phenylmethylsulphonyl fluoride (2.0-200 mu M) which presumably acts by inhibiting the hydrolysis of anandamide in this preparation. The degree of this potentiation increased with the concentration of phenylmethylsulphonyl fluoride used. The methyl analogue of anandamide, R-(+)-arachidonyl-l'-hydroxy-2'-propylamide, also inhibited contractions of the guinea-pig myenteric plexus preparation. The potency of this compound was much less affected by phenylmethylsulphonyl fluoride than was the potency of anandamide, confirming its greater resistance to hydrolysis. Phenylmethylsulphonyl fluoride did not alter the inhibitory potency of the cannabinoid, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxypropyl]cyclohexan-1-ol), which is not an amidase substrate. Nor did phenylmethylsulphonyl fluoride affect the ability of anandamide to inhibit electrically evoked contractions of the mouse vas deferens, suggesting that anandamide does not undergo hydrolysis in this tissue.",
keywords = "CANNABINOID, PHENYLMETHYLSULFONYL FLUORIDE, ANANDAMIDE, R-(+)-ARACHIDONYL-1'-HYDROXY-2'-PROPYLAMIDE VAS DEFERENS, MOUSE, MYENTERIC PLEXUS PREPARATION, GUINEA-PIG, CANNABINOID RECEPTOR, MYENTERIC PLEXUS, GUINEA-PIG, cannabinoid, phenylmethylsulfonyl fluoride, anandamide, R-(+)-arachidonyl-1-hydroxy-2'-propylamide vas deferens, mouse, myenteric plexus preparation, guinea-pig",
author = "Pertwee, {Roger Guy} and Fernando, {S R} and G Griffin and V Abadji and A Makriyannis",
year = "1995",
month = "1",
day = "5",
doi = "10.1016/0014-2999(94)00618-H",
language = "English",
volume = "272",
pages = "73--78",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effect of phenylmethylsulfonyl fluoride on the potency of anandamide as an inhibitor of electrically-evoked contractions in 2 isolated tissue preparations

AU - Pertwee, Roger Guy

AU - Fernando, S R

AU - Griffin, G

AU - Abadji, V

AU - Makriyannis, A

PY - 1995/1/5

Y1 - 1995/1/5

N2 - The endogenous cannabinoid receptor ligand, anandamide, produced a concentration related inhibition of electrically evoked contractions of the guinea-pig myenteric plexus preparation. Its potency was markedly enhanced by phenylmethylsulphonyl fluoride (2.0-200 mu M) which presumably acts by inhibiting the hydrolysis of anandamide in this preparation. The degree of this potentiation increased with the concentration of phenylmethylsulphonyl fluoride used. The methyl analogue of anandamide, R-(+)-arachidonyl-l'-hydroxy-2'-propylamide, also inhibited contractions of the guinea-pig myenteric plexus preparation. The potency of this compound was much less affected by phenylmethylsulphonyl fluoride than was the potency of anandamide, confirming its greater resistance to hydrolysis. Phenylmethylsulphonyl fluoride did not alter the inhibitory potency of the cannabinoid, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxypropyl]cyclohexan-1-ol), which is not an amidase substrate. Nor did phenylmethylsulphonyl fluoride affect the ability of anandamide to inhibit electrically evoked contractions of the mouse vas deferens, suggesting that anandamide does not undergo hydrolysis in this tissue.

AB - The endogenous cannabinoid receptor ligand, anandamide, produced a concentration related inhibition of electrically evoked contractions of the guinea-pig myenteric plexus preparation. Its potency was markedly enhanced by phenylmethylsulphonyl fluoride (2.0-200 mu M) which presumably acts by inhibiting the hydrolysis of anandamide in this preparation. The degree of this potentiation increased with the concentration of phenylmethylsulphonyl fluoride used. The methyl analogue of anandamide, R-(+)-arachidonyl-l'-hydroxy-2'-propylamide, also inhibited contractions of the guinea-pig myenteric plexus preparation. The potency of this compound was much less affected by phenylmethylsulphonyl fluoride than was the potency of anandamide, confirming its greater resistance to hydrolysis. Phenylmethylsulphonyl fluoride did not alter the inhibitory potency of the cannabinoid, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-[3-hydroxypropyl]cyclohexan-1-ol), which is not an amidase substrate. Nor did phenylmethylsulphonyl fluoride affect the ability of anandamide to inhibit electrically evoked contractions of the mouse vas deferens, suggesting that anandamide does not undergo hydrolysis in this tissue.

KW - CANNABINOID

KW - PHENYLMETHYLSULFONYL FLUORIDE

KW - ANANDAMIDE

KW - R-(+)-ARACHIDONYL-1'-HYDROXY-2'-PROPYLAMIDE VAS DEFERENS, MOUSE

KW - MYENTERIC PLEXUS PREPARATION, GUINEA-PIG

KW - CANNABINOID RECEPTOR

KW - MYENTERIC PLEXUS

KW - GUINEA-PIG

KW - cannabinoid

KW - phenylmethylsulfonyl fluoride

KW - anandamide

KW - R-(+)-arachidonyl-1-hydroxy-2'-propylamide vas deferens

KW - mouse

KW - myenteric plexus preparation

KW - guinea-pig

U2 - 10.1016/0014-2999(94)00618-H

DO - 10.1016/0014-2999(94)00618-H

M3 - Article

VL - 272

SP - 73

EP - 78

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -